[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TW238246B - Pharmaceutical composition for reducing the renal toxicity and enhancing the effect of antitumor - Google Patents

Pharmaceutical composition for reducing the renal toxicity and enhancing the effect of antitumor

Info

Publication number
TW238246B
TW238246B TW082108799A TW82108799A TW238246B TW 238246 B TW238246 B TW 238246B TW 082108799 A TW082108799 A TW 082108799A TW 82108799 A TW82108799 A TW 82108799A TW 238246 B TW238246 B TW 238246B
Authority
TW
Taiwan
Prior art keywords
reducing
pharmaceutical composition
antitumor
enhancing
effect
Prior art date
Application number
TW082108799A
Other languages
Chinese (zh)
Inventor
Kawabata Hironori
Moriguchi Koei
Endo Takeshi
Original Assignee
Fuji Chem Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Chem Ind Co Ltd filed Critical Fuji Chem Ind Co Ltd
Application granted granted Critical
Publication of TW238246B publication Critical patent/TW238246B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A pharmaceutical composition for reducing the renal toxicity due to the platinum mixture in organic body is composed of the effective composition of SAMe and its sulfate, and shaping agent and/or aid drug.
TW082108799A 1993-09-03 1993-10-22 Pharmaceutical composition for reducing the renal toxicity and enhancing the effect of antitumor TW238246B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP125093 1993-09-03

Publications (1)

Publication Number Publication Date
TW238246B true TW238246B (en) 1995-01-11

Family

ID=51483955

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082108799A TW238246B (en) 1993-09-03 1993-10-22 Pharmaceutical composition for reducing the renal toxicity and enhancing the effect of antitumor

Country Status (1)

Country Link
TW (1) TW238246B (en)

Similar Documents

Publication Publication Date Title
AU578428B2 (en) Trace-labeled conjugates of metallothionein and target- seeking biologically active molecules
NZ335146A (en) N-(N'-substituted glycyl)-2-cyanopyrrolidine derivatives and medicaments
RS49721B (en) Composition containing herb and surfaction useful in production of products for treatmen of herpes and other microbial infections
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
HRP930239A2 (en) Anti-inflamatory 4-aminophenol derivatives
AU6414994A (en) Composition and method for reducing toxicity of biologically-active factors
MY132705A (en) Novel compounds with analgesic effect
NZ337246A (en) Pharmaceutical composition comprising amoxycillin and clavulanate
HK1028957A1 (en) Use of n,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of chronic pain
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
EP1294375A4 (en) Method of treatment of seborrheic dermatitis
PT78628A (en) Pharmaceutical composition with reduced toxicity
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
ZA963784B (en) Terpenoidic derivatives useful as antitumor agents.
TW238246B (en) Pharmaceutical composition for reducing the renal toxicity and enhancing the effect of antitumor
MY108692A (en) Topical composition
ES8607217A1 (en) Improvements in or relating to anticonvulsant agents.
EP0831869A4 (en) Diphosphonate derivatives of therapeutic agents
GB2306885B (en) Supersaturated Pharmaceutical Compositions
PT1058544E (en) INHIBITION OF TNF ACTIVITY
HU900525D0 (en) Process for the production of medical preparations for treating endotoxinemy
ZA947401B (en) Use of partially methylated beta-cyclodextrins as absorption promoters in the preparation of pharmaceutical compositions for the transcutaneous administration of active principles
UA29639A (en) An antitumor agent
ES2165382T3 (en) ANTIATEROESCLEROTIC AGENTS.